Learn more about rebound hyperbilirubinemia in newborns, including its causes, symptoms and treatment options.

Integrating genetic data with immunological and blood testing can improve detection of HDFN due to ABO incompatibility, a ...

Nipocalimab, an emerging therapeutic agent for hemolytic disease of the fetus and newborn (HDFN), does not appear to affect ...

The FDA approved Johnson & Johnson’s nipocalimab, which is also being studied as a potential treatment in HDFN, in myasthenia ...

Fenofibrate therapy may significantly lower bilirubin levels in full-term infants with newborn jaundice who have levels below ...

A cohort study of 20 pregnancies complicated by HDFN highlights the correlation between early diagnosis and favorable ...

Courtesy Getty Images Learn about where and how to find information related to HDFN research, diagnosis, clinical trials and treatments. If you had a previous pregnancy affected by hemolytic disease ...

FcRn antagonists like nipocalimab can prevent dangerous levels of maternal antibodies from harming developing babies. This review highlights the potential of FcRn antagonists like nipocalimab to ...